Inflammatory myopathies and systemic disorders: A review of immunopathogenetic mechanisms and clinical features

Journal of Neurology

Volumn 244, Issue 5, 1997, Pages 277-287

  Mantegazza, Renato ^a   Bernasconi, Pia ^a   Confalonieri, Paolo ^a   Cornelio, Ferdinando ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Autoimmunity; Collagen vascular diseases; Inflammatory myopathies; Malignancies; Muscle

Indexed keywords

AUTOIMMUNITY; CANCER; DERMATOMYOSITIS; DIAGNOSIS; ETIOLOGY; HUMAN; INCLUSION BODY MYOSITIS; INFLAMMATION; MONONUCLEAR CELL; MUSCLE ATROPHY; MYOPATHY; MYOSITIS; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW;

DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MYOSITIS; MYOSITIS, INCLUSION BODY; POLYMYOSITIS;

EID: 0030976227     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050087     Document Type: Review

References (67)

1. Adler S, Brück W, Warzok R, et al (1996) The role of apoptosis in myositis. J Neurol 243 [Suppl 2]: 112
2. Adler S, Zettl H, Brück W, et al (1996) Apoptotic lymphocyte death in dermatomyositis. J Neurol 243 [Suppl 2]: 30
3. Andreetta F, Bernasconi P, Torchiana E, et al (1995) T cell infiltration in polymyositis is characterized by co-expression of cytotoxic and T-cell activating cytokine transcripts. Ann N Y Acad Sci 756: 418-420
4. Arahata K, Engel AG (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibres invaded by T cells. Ann Neurol 16: 193-208
5. Askanas V, Engel WK (1995) New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Curr Opin Rheumatol 7: 486-496
6. Bartoccioni E, Gallucci S, Scuderi F, et al (1994) MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-I) expression in inflammatory myopathies. Clin Exp Immunol 95: 166-172
7. Basta M, Dalakas MC (1994) High dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 94: 1729-1735
8. Beauchamp JR, Abraham DJ, Bou-Gharios G, et al (1992) Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture. Am J Pathol 140: 387-401
9. + T cells. J Exp Med 181: 1863-1868
10. Berke G (1993) The functions and mechanisms of action of cytolytic lymphocytes. In: Paul WE (ed) Fundamental immunology, Raven Press, New York, pp 965-1014
11. Berke G (1994) The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Ann Rev Immunol 12: 735-773
12. Bertorini TE (1988) Histopathology of the inflammatory myopathies. In: Dalakas MC (ed) Polymyositis and Dermatomyositis. Butterworths, Boston, pp 157-194
13. Callen JP (1994) Myositis and malignancy. Curr Opin Rheumatol 6: 590-594
14. Cenciarelli C, Hou D, Hsu KC, et al (1992) Activation-induced ubiquitination of the T cell antigen receptor. Science 257: 795-797
15. Chothia C, Boswell DR, Lesk AM (1988) The outline structure of the T-cell αβ receptor. EMBO J 7: 3745-3755
16. Cohen R, Lipper S, Dantzker DR (1993) Inclusion body myositis as a cause of respiratory failure. Chest 104: 975-977
17. Daar AS, Fuggle SV, Fabre JW, et al (1984) The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 38: 287-292
18. Daar AS, Fuggle SV, Fabre JW, et al (1984) The detailed distribution of MHC class II antigens in normal human organs. Transplantation 38: 293-298
19. Dalakas MC (1992) Clinical, immunopathologic, and therapeutic considerations of inflammatory myopathies. Clin Neuropharmacol 15: 327-351
20. Dalakas MC (1995) Immunopathogenesis of inflammatory myopathies. Ann Neurol 37 [Suppl 1]: 74-86
21. De Bleecker JL, Engel AG (1994) Expression of cell adhesion in inflammatory myopathies and Duchenne dystrophy. J Neuropathol Exp Neurol 53: 369-376
22. De Bleecker JL, Engel AG (1995) Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies. Am J Pathol 146: 1178-1187
23. Emslie-Smith AM, Engel AG (1990) Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 27: 343-356
24. Emslie-Smith AM, Arahata K, Engel AG (1989) Major histocompatibility complex class I antigen expression, immunolocalization of Interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 20: 224-231
25. Engel AG, Arahata K (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion-body myositis. Ann Neurol 16: 209-215
26. Engel AG, Hohlfeld R, Banker BQ (1994) Inflammatory myopathies. The polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1335-1383
27. Goebels N, Michaelis D, Wekerle H, Hohlfeld R (1992) Human myoblasts as antigen-presenting cells. J Immunol 149: 661-667
28. Hardiman O, Faustman D, Li X, et al (1993) Expression of major histocompatibility complex antigens in cultures of clonally derived human myoblasts. Neurology 43: 604-608
29. Hockenbery DM, Zutter M, Hickey W, et al (1991) BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961-6965
30. Hohlfeld R, Engel AG (1990) Induction of HLA-DR expression on human myoblasts with interferon-gamma. Am J Pathol 136: 503-508
31. Hohlfeld R, Engel AG (1991) Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies. Ann Neurol 29: 498-507
32. Hohlfeld R, Engel AG, Li K, Harper MC (1991) Polymyositis mediated by T lymphocytes that express the y/δ receptor. N Engl J Med 324: 877-881
33. Hohlfeld R, Engel AG (1994) The immunobiology of muscle. Immunol Today 15: 269-274
34. Itoh N, Yonehara S, Ishii A, et al (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243
35. Kägi D, Ledermann B, Bürkl K, et al (1994) Cytotoxicity mediated by T cells is greatly impaired in perforin-deficient mice. Nature 369: 31-37
36. Karpati G, Pouliot Y, Carpenter S (1988) Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 23: 64-72
37. Kissel JT, Mendell JR, Rammohan KW (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 314: 329-334
38. Koh ET, Seow A, Ong B, et al (1993) Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis 52: 857-861
39. Lindberg C, Oldfors A, Tarkowski A (1994) Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies. Eur J Immunol 24: 2659-2663
40. Liu C-C, Walsh CM, Young JD-E (1995) Perforin: structure and function. Immunol Today 16: 194-201
41. Lundberg I, Brengman JM, Engel AG (1995) Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. J Neuroimmunol 63: 9-16
42. Mantegazza R, Hughes SM, Mitchell D, et al (1991) Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-γ. Neurology 41: 1128-1132
43. Mantegazza R, Andreetta F, Bernasconi P, et al (1993) Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. J Clin Invest 91: 2880-2886
44. Mantegazza R, Bernasconi P, Torchiana E, et al (1994) Molecular analysis of T cell receptor repertoire of T cell infiltrates in sporadic and familial inclusion body myositis. Muscle Nerve 17 [Suppl 1|: 117
45. Mantegazza R, Gebbia M, Mora M, et al (1996) Major histocompatibility complex class II molecule expression on muscle cells is regulated by differentiation: implications for the immunopathogenesis of muscle autoimmune diseases. J Neuroimmunol 68: 53-60
46. Mastaglia FL, Laing NG (1996) Investigation of muscle disease. J Neurol Neurosurg Psychiatry 60: 256-274
47. McDouall RM, Dunn MJ, Dubowitz V (1989) Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci 89: 213-226
48. Michaelis D, Goebels N, Hohlfeld R (1993) Costitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am J Pathol 143: 1142-1149
49. Mikol J, Engel AG (1994) Inclusion body myositis. In: Engel AG, FranziniArmstrong C (eds) Myology. McGraw-Hill, New York, pp 1384-1398
50. Miller FW (1993) Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies. JAMA 270: 1846-1849
51. Moss PAH, Rosenberg WMC, Bell JI (1992) The human T cell receptor in health and diseases. Ann Rev Immunol 10: 71-96
52. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW (1994) Predominant TCR-αb variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. J Immunol 152: 2569-2576
53. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW (1994) The αb T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytes. J Autoimmun 7: 321-333
54. O'Hanlon TP, Messersmith WA, Dalakas MC, et al (1995) Gamma delta T cell receptor gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. Clin Exp Immunol 100: 519-528
55. Orimo S, Koga R, Goto K, et al (1994) Immunohistochemical analysis of perform and granzyme A in inflammatory myopathies. Neuromusc Disord 4: 219-226
56. Paul WE, Seder RA (1994) Lymphocyte responses and cytokines. Cell 76: 241-251
57. Pluschke G, Ruegg D, Hohlfeld R, Engel AG (1992) Autoaggressive myocytotoxic T lymphocytes expressing an unusual γ/δ T cell receptor. J Exp Med 176: 1785-1789
58. Pruitt JN, Showalter CJ, Engel AG (1996) Sporadic inclusion body myositis: counts of different types of abnormal fibers. Ann Neurol 39: 139-143
59. Romagnani S (1994) Lymphokine production by human T cells in disease states. Ann Rev Immunol 12: 227-257
60. Sandri M, Carraro U, Podhorska-Okolov M, et al (1995) Apoptosis. DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Lett 373: 291-295
61. Smyth MJ, Trapani JA (1995) Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 16: 202-206
62. Tews DS, Goebel HH (1995) Expression of cell adhesion molecules in inflammatory myopathies. J Neuroimmunol 59: 185-194
63. Tews DS, Goebel HH (1996) Cytokine expression profiles in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol 55: 342-347
64. Tokano Y, Obara T, Hashimoto H, et al (1993) Soluble CD4, CD8 in patients with polymyositis/dermatomyositis. Clin Rheumatol 12: 368-374
65. Wolf RE, Baethge BA (1990) Interleukin-1α, interleukin-2, and soluble interleukin-2 receptors in polymyositis. Arthritis Rheum 33: 1007-1014
66. Yamada H, Nakagawa M, Higuchi I, et al (1995) Type II muscle fibers are stained by anti-Fas antibody. J Neurol Sci 134: 115-118
67. Zeviani M, Amati P, Savoia A (1994) Mitochondrial myopathies. Curr Opin Rheumatol 6: 559-567